v3.25.2
Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Recurring Fair Value Measurements
The following table presents information about the Company’s assets and liabilities measured at fair value as of June 30, 2025 and December 31, 2024, aggregated by the level in the fair value hierarchy within which those instruments fall.
(In thousands)Quoted Prices in Active Markets
Level 1
Significant
Other Observable Inputs
Level 2
Significant Unobservable Inputs
Level 3
Total
June 30, 2025
Derivative assets, at fair value (non-designated)$— $1,755 $— $1,755 
Derivative assets, at fair value (designated)— 9,453 — 9,453 
Total $— $11,208 $— $11,208 
December 31, 2024
Derivative assets, at fair value (non-designated)$— $2,554 $— $2,554 
Derivative assets, at fair value (designated)— 16,652 — 16,652 
Total $— $19,206 $— $19,206 
Schedule of Fair Value by Balance Sheet
The fair values of the Company’s remaining financial instruments that are not reported at fair value on the consolidated balance sheets are reported below:
June 30, 2025December 31, 2024
(In thousands)LevelCarrying Amount Fair Value Carrying AmountFair Value 
Gross mortgage notes payable and mortgage premium and discounts, net
3$705,024 $684,141 $788,464 $747,542 
Credit facilities3337,624 338,792 362,216 362,974 
Total debt$1,042,648 $1,022,933 $1,150,680 $1,110,516